Rlip depletion prevents spontaneous neoplasia in TP53 null mice

Sanjay Awasthi, Joshua Tompkins, Jyotsana Singhal, Arthur D. Riggs, Sushma Yadav, Xiwei Wu, Sharda Singh, Charles Warden, Zheng Liu, Jinhui Wang, Thomas P. Slavin, Jeffrey N. Weitzel, Yate Ching Yuan, Meenakshi Awasthi, Satish Srivastava, Yogesh C. Awasthi, Sharad S. Singhal

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

TP53 (p53) is a tumor suppressor whose functions are lost or altered in most malignancies. p53 homozygous knockout (p53/) mice uniformly die of spontaneous malignancy, typically T-cell lymphoma. RALBP1 (RLIP76, Rlip) is a stress-protective, mercapturic acid pathway transporter protein that also functions as a Ral effector involved in clathrin-dependent endocytosis. In stark contrast to p53/ mice, Rlip/ mice are highly resistant to carcinogenesis. We report here that partial Rlip deficiency induced by weekly administration of an Rlip-specific phosphorothioate antisense oligonucleotide, R508, strongly inhibited spontaneous as well as benzo(a)pyrene-induced carcinogenesis in p53/ mice. This treatment effectively prevented large-scale methylomic and transcriptomic abnormalities suggestive of inflammation found in cancer-bearing p53/ mice. The remarkable efficiency with which Rlip deficiency suppresses spontaneous malignancy in p53/ mice has not been observed with any previously reported pharmacologic or genetic intervention. These findings are supported by cross-breeding experiments demonstrating that hemizygous Rlip deficiency also reduces the spontaneous malignancy phenotype of p53+/ mice. Rlip is found on the cell surface, and antibodies directed against Rlip were found to inhibit growth and promote apoptosis of cell lines as effectively as Rlip siRNA. The work presented here investigates several features, including oxidative DNA damage of the Rlip-p53 association in malignant transformation, and offers a paradigm for the mechanisms of tumor suppression by p53 and the prospects of suppressing spontaneous malignancy in hereditary cancer syndromes such as Li-Fraumeni.

Original languageEnglish (US)
Pages (from-to)3918-3923
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume115
Issue number15
DOIs
StatePublished - Jan 1 2018

Fingerprint

Neoplasms
Carcinogenesis
Hereditary Neoplastic Syndromes
Phosphorothioate Oligonucleotides
Clathrin
Genetic Engineering
T-Cell Lymphoma
Antisense Oligonucleotides
Benzo(a)pyrene
Acetylcysteine
Endocytosis
Knockout Mice
Small Interfering RNA
DNA Damage
Breeding
Apoptosis
Inflammation
Phenotype
Cell Line
Antibodies

Keywords

  • Cancer prevention
  • Cancer signalling
  • Cytokine
  • RALBP1
  • TP53

ASJC Scopus subject areas

  • General

Cite this

Awasthi, S., Tompkins, J., Singhal, J., Riggs, A. D., Yadav, S., Wu, X., ... Singhal, S. S. (2018). Rlip depletion prevents spontaneous neoplasia in TP53 null mice. Proceedings of the National Academy of Sciences of the United States of America, 115(15), 3918-3923. https://doi.org/10.1073/pnas.1719586115

Rlip depletion prevents spontaneous neoplasia in TP53 null mice. / Awasthi, Sanjay; Tompkins, Joshua; Singhal, Jyotsana; Riggs, Arthur D.; Yadav, Sushma; Wu, Xiwei; Singh, Sharda; Warden, Charles; Liu, Zheng; Wang, Jinhui; Slavin, Thomas P.; Weitzel, Jeffrey N.; Yuan, Yate Ching; Awasthi, Meenakshi; Srivastava, Satish; Awasthi, Yogesh C.; Singhal, Sharad S.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, No. 15, 01.01.2018, p. 3918-3923.

Research output: Contribution to journalArticle

Awasthi, S, Tompkins, J, Singhal, J, Riggs, AD, Yadav, S, Wu, X, Singh, S, Warden, C, Liu, Z, Wang, J, Slavin, TP, Weitzel, JN, Yuan, YC, Awasthi, M, Srivastava, S, Awasthi, YC & Singhal, SS 2018, 'Rlip depletion prevents spontaneous neoplasia in TP53 null mice', Proceedings of the National Academy of Sciences of the United States of America, vol. 115, no. 15, pp. 3918-3923. https://doi.org/10.1073/pnas.1719586115
Awasthi, Sanjay ; Tompkins, Joshua ; Singhal, Jyotsana ; Riggs, Arthur D. ; Yadav, Sushma ; Wu, Xiwei ; Singh, Sharda ; Warden, Charles ; Liu, Zheng ; Wang, Jinhui ; Slavin, Thomas P. ; Weitzel, Jeffrey N. ; Yuan, Yate Ching ; Awasthi, Meenakshi ; Srivastava, Satish ; Awasthi, Yogesh C. ; Singhal, Sharad S. / Rlip depletion prevents spontaneous neoplasia in TP53 null mice. In: Proceedings of the National Academy of Sciences of the United States of America. 2018 ; Vol. 115, No. 15. pp. 3918-3923.
@article{b7ea9d4f9af24afc8936615103a9e635,
title = "Rlip depletion prevents spontaneous neoplasia in TP53 null mice",
abstract = "TP53 (p53) is a tumor suppressor whose functions are lost or altered in most malignancies. p53 homozygous knockout (p53−/−) mice uniformly die of spontaneous malignancy, typically T-cell lymphoma. RALBP1 (RLIP76, Rlip) is a stress-protective, mercapturic acid pathway transporter protein that also functions as a Ral effector involved in clathrin-dependent endocytosis. In stark contrast to p53−/− mice, Rlip−/− mice are highly resistant to carcinogenesis. We report here that partial Rlip deficiency induced by weekly administration of an Rlip-specific phosphorothioate antisense oligonucleotide, R508, strongly inhibited spontaneous as well as benzo(a)pyrene-induced carcinogenesis in p53−/− mice. This treatment effectively prevented large-scale methylomic and transcriptomic abnormalities suggestive of inflammation found in cancer-bearing p53−/− mice. The remarkable efficiency with which Rlip deficiency suppresses spontaneous malignancy in p53−/− mice has not been observed with any previously reported pharmacologic or genetic intervention. These findings are supported by cross-breeding experiments demonstrating that hemizygous Rlip deficiency also reduces the spontaneous malignancy phenotype of p53+/− mice. Rlip is found on the cell surface, and antibodies directed against Rlip were found to inhibit growth and promote apoptosis of cell lines as effectively as Rlip siRNA. The work presented here investigates several features, including oxidative DNA damage of the Rlip-p53 association in malignant transformation, and offers a paradigm for the mechanisms of tumor suppression by p53 and the prospects of suppressing spontaneous malignancy in hereditary cancer syndromes such as Li-Fraumeni.",
keywords = "Cancer prevention, Cancer signalling, Cytokine, RALBP1, TP53",
author = "Sanjay Awasthi and Joshua Tompkins and Jyotsana Singhal and Riggs, {Arthur D.} and Sushma Yadav and Xiwei Wu and Sharda Singh and Charles Warden and Zheng Liu and Jinhui Wang and Slavin, {Thomas P.} and Weitzel, {Jeffrey N.} and Yuan, {Yate Ching} and Meenakshi Awasthi and Satish Srivastava and Awasthi, {Yogesh C.} and Singhal, {Sharad S.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1073/pnas.1719586115",
language = "English (US)",
volume = "115",
pages = "3918--3923",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "15",

}

TY - JOUR

T1 - Rlip depletion prevents spontaneous neoplasia in TP53 null mice

AU - Awasthi, Sanjay

AU - Tompkins, Joshua

AU - Singhal, Jyotsana

AU - Riggs, Arthur D.

AU - Yadav, Sushma

AU - Wu, Xiwei

AU - Singh, Sharda

AU - Warden, Charles

AU - Liu, Zheng

AU - Wang, Jinhui

AU - Slavin, Thomas P.

AU - Weitzel, Jeffrey N.

AU - Yuan, Yate Ching

AU - Awasthi, Meenakshi

AU - Srivastava, Satish

AU - Awasthi, Yogesh C.

AU - Singhal, Sharad S.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - TP53 (p53) is a tumor suppressor whose functions are lost or altered in most malignancies. p53 homozygous knockout (p53−/−) mice uniformly die of spontaneous malignancy, typically T-cell lymphoma. RALBP1 (RLIP76, Rlip) is a stress-protective, mercapturic acid pathway transporter protein that also functions as a Ral effector involved in clathrin-dependent endocytosis. In stark contrast to p53−/− mice, Rlip−/− mice are highly resistant to carcinogenesis. We report here that partial Rlip deficiency induced by weekly administration of an Rlip-specific phosphorothioate antisense oligonucleotide, R508, strongly inhibited spontaneous as well as benzo(a)pyrene-induced carcinogenesis in p53−/− mice. This treatment effectively prevented large-scale methylomic and transcriptomic abnormalities suggestive of inflammation found in cancer-bearing p53−/− mice. The remarkable efficiency with which Rlip deficiency suppresses spontaneous malignancy in p53−/− mice has not been observed with any previously reported pharmacologic or genetic intervention. These findings are supported by cross-breeding experiments demonstrating that hemizygous Rlip deficiency also reduces the spontaneous malignancy phenotype of p53+/− mice. Rlip is found on the cell surface, and antibodies directed against Rlip were found to inhibit growth and promote apoptosis of cell lines as effectively as Rlip siRNA. The work presented here investigates several features, including oxidative DNA damage of the Rlip-p53 association in malignant transformation, and offers a paradigm for the mechanisms of tumor suppression by p53 and the prospects of suppressing spontaneous malignancy in hereditary cancer syndromes such as Li-Fraumeni.

AB - TP53 (p53) is a tumor suppressor whose functions are lost or altered in most malignancies. p53 homozygous knockout (p53−/−) mice uniformly die of spontaneous malignancy, typically T-cell lymphoma. RALBP1 (RLIP76, Rlip) is a stress-protective, mercapturic acid pathway transporter protein that also functions as a Ral effector involved in clathrin-dependent endocytosis. In stark contrast to p53−/− mice, Rlip−/− mice are highly resistant to carcinogenesis. We report here that partial Rlip deficiency induced by weekly administration of an Rlip-specific phosphorothioate antisense oligonucleotide, R508, strongly inhibited spontaneous as well as benzo(a)pyrene-induced carcinogenesis in p53−/− mice. This treatment effectively prevented large-scale methylomic and transcriptomic abnormalities suggestive of inflammation found in cancer-bearing p53−/− mice. The remarkable efficiency with which Rlip deficiency suppresses spontaneous malignancy in p53−/− mice has not been observed with any previously reported pharmacologic or genetic intervention. These findings are supported by cross-breeding experiments demonstrating that hemizygous Rlip deficiency also reduces the spontaneous malignancy phenotype of p53+/− mice. Rlip is found on the cell surface, and antibodies directed against Rlip were found to inhibit growth and promote apoptosis of cell lines as effectively as Rlip siRNA. The work presented here investigates several features, including oxidative DNA damage of the Rlip-p53 association in malignant transformation, and offers a paradigm for the mechanisms of tumor suppression by p53 and the prospects of suppressing spontaneous malignancy in hereditary cancer syndromes such as Li-Fraumeni.

KW - Cancer prevention

KW - Cancer signalling

KW - Cytokine

KW - RALBP1

KW - TP53

UR - http://www.scopus.com/inward/record.url?scp=85045082604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045082604&partnerID=8YFLogxK

U2 - 10.1073/pnas.1719586115

DO - 10.1073/pnas.1719586115

M3 - Article

C2 - 29572430

AN - SCOPUS:85045082604

VL - 115

SP - 3918

EP - 3923

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 15

ER -